Elsevier’s 2025 Intravenous Medications - Edition 41 - By Shelly Rainforth Collins, PharmD, BCGP Elsevier Educate

Purchase textbook

New

Elsevier’s 2025 Intravenous Medications,

Edition 41 A Handbook for Nurses and Health Professionals

By Shelly Rainforth Collins, PharmD, BCGP

Publication Date: 26 Sep 2024

Student ancillaries

0 Reviews

Digital copy not yet available

**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Pharmacology**

Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2025 edition are 16 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.

Key Features

Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference.
Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more.
Additional drug monographs are provided on the Evolve website.
Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks.
Blue-screened text calls attention to special circumstances not covered by Black Box Warnings.
Dosage and dilution charts within monographs provide quick summaries of essential clinical information.
Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds.
Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks.
NEW! Drug monographs for 16 newly approved drugs by the FDA include the most current information.
NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications.
NEW! Best practices guidelines for the preparation and administration of injectable drugs are provided from the National Coalition for IV Push Safety.

About the author

By Shelly Rainforth Collins, PharmD, BCGP, President, Drug Information Consultants, Chesapeake, Virginia, USA

Evolve website information
General Dilution Charts
How to Use This Book
Preface
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
Preparation and Administration of Injectable Drugs
IV Drugs
Appendix A Recommendations for the Safe Use and Handling of Cytotoxic Drugs
Appendix B FDA Pregnancy Categories
Appendix C U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
Appendix D Information for Patients Receiving Immunosuppressive Agents
Appendix E Recently Approved Drugs
Index
Solution Compatibility Chart
Selected Agents Not Included in the Book

ISBN: 9780443120404

Page Count: 1344

Retail Price (USD) :

Alerts Appendixes Calculators and Interactive IV D Do Not Confuse Drug Names Format and Content General Dilation Chart New Drug Updates Section Selected Agents Not Included in Solution Compatibility Chart Tutorial: Step-by-Step Examples